Evan Sisson talks about past concerns around statin risk and notes that there are many trials which have shown that statins, on their own, do not increase CV risk. However, he emphasizes that most of our patients with metabolic disease don’t just take a statin but are on other prescription …

Evan Sisson, notes that, even in the recent past, drug therapy was frequently “one-size-fits-all.” But now, newer agents are coming out that target other matebolic places which can affect LDL cholesterol in many different ways. As the medical community learns more about these other mechanisms, more tailored treatments may become …

Evan Sisson talks about how the foundation of his approach to treating hyperlipidemia with statins is actually lifestyle modification. He notes, however, that patients “can figure out how to out-eat any statin we can give them,” so the best programs are those that involve a team approach. That way, the …